Login Register Cart 0
Generic placeholder image

Letters in Organic Chemistry

Editor-in-Chief

ISSN (Print): 1570-1786
ISSN (Online): 1875-6255

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Molecular Docking of Phytomolecules of Grain Amaranth (Amaranthus hypochondriacus) with AKR1C3Protein Involved in Prostate Cancer in Human Beings

Author(s): Dinesh Pandey*, Manisha Bharti, Anubhav Rana, Sharat Prabhakaran and Rashmi Chauhan

Volume 21, Issue 8, 2024

Published on: 23 January, 2024

Page: [677 - 686] Pages: 10

DOI: 10.2174/0115701786275607231228094526

Price: $65

conference banner
Abstract

This study focuses on exploring how the bioactive compounds found in amaranth— phytol, squalene, and α-tocopherol—could potentially offer medicinal benefits in the context of prostate cancer. The investigation involves a docking study with AKR1C3, an important target linked to the control of prostate cancer, aiming to uncover their potential effects against this disease. Costeffective and efficient cancer treatment options are crucial because of the high expenses associated with current cancer therapies as well as their side effects. Amaranth (Amaranthus hypochondriacus) is a pseudocereal crop abundant in squalene, α-tocopherol, and phytol, which shows promising foodbased therapy for various diseases, including cancer. Prostate cancer has been a significant contributor to mortality globally, but the introduction of relugolix has emerged as a crucial therapeutic intervention in its treatment. Hence, this study was conducted to investigate the interactions between grain amaranth bioactive compounds squalene, phytol, and α-tocopherol with AKR1C3 protein utilizing a molecular docking approach facilitated by Autodock Vina software. Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB-PDB) (http://www.rcsb.org/) was used for retrieving the 3D crystal structure of the target protein, AKR1C3 (PDB ID: 7c7f). The 3D structure of bioactive compounds squalene, phytol, and α-tocopherol were retrieved from the PubChem database, following which Open-Babel was used to change the format from .sdf to .pdb. Furthermore, pharmacokinetics characteristics were also considered along with Lipinski’s rule of five using SwissADME (http://www. Swiss adme.ch/index.php) and pkCSM (http://structure.bioc.cam.ac.uk/pkcsm), indicating their potential as a drug candidate in the initial stage. The potential anticancer properties of the ligands were predicted using PASS software. Following the completion of the docking study, it became evident that α-tocopherol demonstrated the most significant binding energy, followed by squalene and phytol, in comparison to the established drug, relugolix. This implies that the chosen bioactive compounds might possess enzyme-inhibiting properties, indicating their potential for further in vivo anticancer screening using model organisms. The findings serve as stepping stones for advancing the potential use of the discussed bioactive compounds as a potential drug candidate for prostate cancer.

Keywords: Prostate cancer, AKR1C3, phytol, squalene, α-tocopherol, androgen receptor.

« Previous Next »
Graphical Abstract

[1]
Mattiuzzi, C.; Lippi, G. J. Epidemiol. Glob. Health, 2019, 9(4), 217-222.
[http://dx.doi.org/10.2991/jegh.k.191008.001] [PMID: 31854162]
[2]
Chan, J.M.; Gann, P.H.; Giovannucci, E.L. J. Clin. Oncol., 2005, 23(32), 8152-8160.
[http://dx.doi.org/10.1200/JCO.2005.03.1492] [PMID: 16278466]
[3]
Willis, M.S.; Wians, F.H., Jr Clin. Chim. Acta, 2003, 330(1-2), 57-83.
[http://dx.doi.org/10.1016/S0009-8981(03)00048-2] [PMID: 12636926]
[4]
Giovannucci, E.; Rimm, E.B.; Colditz, G.A.; Stampfer, M.J.; Ascherio, A.; Chute, C.C.; Willett, W.C. J. Natl. Cancer Inst., 1993, 85(19), 1571-1579.
[http://dx.doi.org/10.1093/jnci/85.19.1571] [PMID: 8105097]
[5]
Kolonel, L.N.; Hankin, J.H.; Whittemore, A.S.; Wu, A.H.; Gallagher, R.P.; Wilkens, L.R.; John, E.M.; Howe, G.R.; Dreon, D.M.; West, D.W.; Paffenbarger, R.S., Jr Cancer Epidemiol. Biomarkers Prev., 2000, 9(8), 795-804.
[PMID: 10952096]
[6]
Platz, E.A.; Leitzmann, M.F.; Michaud, D.S.; Willett, W.C.; Giovannucci, E. Cancer Res., 2003, 63(23), 8542-8548.
[PMID: 14679023]
[7]
Suzuki, H.; Ueda, T.; Ichikawa, T.; Ito, H. Endocr. Relat. Cancer, 2003, 10(2), 209-216.
[http://dx.doi.org/10.1677/erc.0.0100209] [PMID: 12790784]
[8]
Ahmed, A.; Ali, S.; Sarkar, F.H. J. Cell. Physiol., 2014, 229(3), 271-276.
[http://dx.doi.org/10.1002/jcp.24456] [PMID: 24037862]
[9]
Balk, S.P.; Ko, Y.J.; Bubley, G.J. J. Clin. Oncol., 2003, 21(2), 383-391.
[http://dx.doi.org/10.1200/JCO.2003.02.083] [PMID: 12525533]
[10]
Liu, C.; Lou, W.; Zhu, Y.; Yang, J.C.; Nadiminty, N.; Gaikwad, N.W.; Evans, C.P.; Gao, A.C. Cancer Res., 2015, 75(7), 1413-1422.
[http://dx.doi.org/10.1158/0008-5472.CAN-14-3080] [PMID: 25649766]
[11]
Matsunaga, T.; Hojo, A.; Yamane, Y.; Endo, S.; El-Kabbani, O.; Hara, A. Chem. Biol. Interact., 2013, 202(1-3), 234-242.
[http://dx.doi.org/10.1016/j.cbi.2012.09.024] [PMID: 23165153]
[12]
Sun, S.Q.; Gu, X.; Gao, X.S.; Li, Y.; Yu, H.; Xiong, W.; Yu, H.; Wang, W.; Li, Y.; Teng, Y.; Zhou, D. Oncotarget, 2016, 7(30), 48050-48058.
[http://dx.doi.org/10.18632/oncotarget.10347] [PMID: 27385003]
[13]
Wang, B.; Gu, Y.; Hui, K.; Huang, J.; Xu, S.; Wu, S.; Li, L.; Fan, J.; Wang, X.; Hsieh, J.T.; He, D. Urol. Oncol; Semin. Orig. Investigat, 2018, p. 472.
[14]
Penning, T.M. Chemi-Biol. Intera., 2015, 234, 236-246.
[15]
Penning, T.M. Mol. Cell. Endocrinol., 2019, 489, 82-91.
[http://dx.doi.org/10.1016/j.mce.2018.07.002] [PMID: 30012349]
[16]
Hamid, A.R.A.; Pfeiffer, M.J.; Verhaegh, G.W.; Schaafsma, E.; Brandt, A.; Sweep, F.C.; Sedelaar, J.P.; Schalken, J.A. Mol. Med., 2013, 18(1), 1449-1455.
[PMID: 23196782]
[17]
Powell, K.; Semaan, L.; Conley-LaComb, M.K.; Asangani, I.; Wu, Y.M.; Ginsburg, K.B.; Williams, J.; Squire, J.A.; Maddipati, K.R.; Cher, M.L.; Chinni, S.R. Clin. Cancer Res., 2015, 21(11), 2569-2579.
[http://dx.doi.org/10.1158/1078-0432.CCR-14-2352] [PMID: 25754347]
[18]
Jernberg, E.; Thysell, E.; Bovinder Ylitalo, E.; Rudolfsson, S.; Crnalic, S.; Widmark, A.; Bergh, A.; Wikström, P. PLoS One, 2013, 8(11)e77407
[http://dx.doi.org/10.1371/journal.pone.0077407] [PMID: 24244276]
[19]
Sharma, R.; Jain, S. J. Pharm. Pharm. Sci., 2014, 3(8), 222-230.
[20]
Krishnamoorthy, K.; Subramaniam, P. Int. Sch. Res. Notices,; , 2014.
[21]
Durhan, B.; Yalçın, E.; Çavuşoğlu, K.; Acar, A. Sci. Rep., 2022, 12(1), 4308.
[http://dx.doi.org/10.1038/s41598-022-08421-8] [PMID: 35279686]
[22]
Santos, C.C.D.M.P.; Salvadori, M.S.; Mota, V.G.; Costa, L.M.; de Almeida, A.A.C.; de Oliveira, G.A.L.; Costa, J.P.; de Sousa, D.P.; de Freitas, R.M.; de Almeida, R.N. Neurosci. J., 2013, 2013949452
[23]
Faix, Š.; Juhas, Š.; Faixová, Z. Acta Vet. Brno, 2007, 76(3), 357-361.
[http://dx.doi.org/10.2754/avb200776030357]
[24]
de Alencar, M.V.O.B.; Islam, M.T.; de Lima, R.M.T.; Paz, M.F.C.J.; dos Reis, A.C.; da Mata, A.M.O.F.; Filho, J.W.G.O.; Cerqueira, G.S.; Ferreira, P.M.P.; Sousa, J.M.C.; Mubarak, M.S.; Melo-Cavalcante, A.A.C. IUBMB Life, 2019, 71(2), 200-212.
[http://dx.doi.org/10.1002/iub.1952] [PMID: 30394663]
[25]
Brigelius-Flohé, R. Kelly, F.J.; Salonen, J.T.; Neuzil, J.; Zingg, J.M.; Azzi. A. A.G.C.N, 2002, 76(4), 703-716.
[26]
Ju, J.; Picinich, S.C.; Yang, Z.; Zhao, Y.; Suh, N.; Kong, A.N.; Yang, C.S. Carcinogenesis, 2010, 31(4), 533-542.
[http://dx.doi.org/10.1093/carcin/bgp205] [PMID: 19748925]
[27]
Lehmann, J.W.; Putnam, D.H.; Qureshi, A.A. Lipids, 1994, 29(3), 177-181.
[http://dx.doi.org/10.1007/BF02536726]
[28]
Taylor, P.R.; Qiao, Y.L.; Abnet, C.C.; Dawsey, S.M.; Yang, C.S.; Gunter, E.W.; Wang, W.; Blot, W.J.; Dong, Z.W.; Mark, S.D. J. Natl. Cancer Inst., 2003, 95(18), 1414-1416.
[http://dx.doi.org/10.1093/jnci/djg044] [PMID: 13130117]
[29]
Mahabir, S. Schendel, K.; Dong, Y.Q.; Barrera, S.L.; Spitz, M.R.; Forman. M.R. I.J.C, 2008, 123(5), 1173-1180.
[30]
Virtamo, J. Taylor, P.R.; Kontto, J.; Manniato, S.; Utriainen, M.; Weinstein, S.j.; Huttunen, J.; Albanes. D. I.J.C, 2014, 135(1), 178-185.
[31]
Newmark, H.L. Cancer Epidemiol. Biomarkers Prev., 1997, 6(12), 1101-1103.
[PMID: 9419410]
[32]
Miettinen, T.A.; Vanhanen, H. Am. J. Clin. Nutr., 1994, 59(2), 356-363.
[http://dx.doi.org/10.1093/ajcn/59.2.356] [PMID: 8310985]
[33]
Rao, C.; Newmark, H.L.; Reddy, B.S. Carcinogenesis, 1998, 19(2), 287-290.
[http://dx.doi.org/10.1093/carcin/19.2.287] [PMID: 9498278]
[34]
Czaplicki, S.; Ogrodowska, D.; Derewiaka, D. Tańska, M.; Zadernowski, R. Eur. J. Lipid Sci. Technol., 2011, 113(12), 1456-1464.
[http://dx.doi.org/10.1002/ejlt.201000410]
[35]
Saunders, R.M.; Becker, R. Adv. Cereal. Sci. Technol., 1983, 6, 357-396.
[36]
Jahaniaval, F. Kakuda, Y.; Marcone. M.F. J.O.A.C.S, 2000, 77, 847-852.
[37]
Chauhan, R.; Prabhakran, S.; Aswal, K.; Pandey, D. Lett. Org. Chem., 2023, 20(9), 829-836.
[38]
Cruz-Vicente, P.; Passarinha, L.A.; Silvestre, S.; Gallardo, E. Molecules, 2021, 26(8), 2193.
[http://dx.doi.org/10.3390/molecules26082193] [PMID: 33920326]
[39]
Seyedi, S.S.; Shukri, M.; Hassandarvish, P.; Oo, A.; Shankar, E.M.; Abubakar, S.; Zandi, K. Sci. Rep., 2016, 6(1), 24027.
[http://dx.doi.org/10.1038/srep24027] [PMID: 27071308]
[40]
Lounnas, V.; Ritschel, T.; Kelder, J.; McGuire, R.; Bywater, R.P.; Foloppe, N. Comput. Struct. Biotechnol. J., 2013, 5(6)e201302011
[http://dx.doi.org/10.5936/csbj.201302011] [PMID: 24688704]
[41]
Ferreira, L.G.; dos Santos, R.N. Mol. Docking Struct.-. Based Drug Des. Strategies Mol., 2015, 20, 13384-13421.
[42]
Yuriev, E.; Ramsland, P.A. J. Mol. Recognit., 2013, 26(5), 215-239.
[http://dx.doi.org/10.1002/jmr.2266]
[43]
Reed, L.; Arlt, V.M.; Phillips, D.H. Carcinogenesis, 2018, 39(7), 851-859.
[http://dx.doi.org/10.1093/carcin/bgy058] [PMID: 29726902]
[44]
Adegoke, H.I.; Adekola, F.A.; Fatoki, O.S.; Ximba, B.J. Pol. J. Environ. Stud., 2013, 22(1)
[45]
Dash, R.; Uddin, M.M.; Hosen, S.M.Z.; Rahim, Z.B.; Dinar, A.; Kabir, M.; Sultan, R.A.; Islam, A.; Hossain, M.K. Bioinformation, 2015, 11(12), 543-549.
[http://dx.doi.org/10.6026/97320630011543] [PMID: 26770028]
[46]
Liedtke, A.J.; Adeniji, A.O.; Chen, M.; Byrns, M.C.; Jin, Y.; Christianson, D.W.; Marnett, L.J.; Penning, T.M. J. Med. Chem., 2013, 56(6), 2429-2446.
[http://dx.doi.org/10.1021/jm3017656] [PMID: 23432095]
[47]
Komoto, J.; Yamada, T.; Watanabe, K.; Takusagawa, F. Biochemistry, 2004, 43(8), 2188-2198.
[http://dx.doi.org/10.1021/bi036046x] [PMID: 14979715]
[48]
Flanagan, J.U.; Yosaatmadja, Y.; Teague, R.M.; Chai, M.Z.; Turnbull, A.P.; Squire, C.J. PLoS One, 2012, 7(8)e43965
[49]
Qiu, W.; Zhou, M.; Mazumdar, M.; Azzi, A.; Ghanmi, D.; Luu-The, V.; Labrie, F.; Lin, S.X. J. Biol. Chem., 2007, 282(11), 8368-8379.
[http://dx.doi.org/10.1074/jbc.M606784200] [PMID: 17166832]
[50]
Chen, M.; Adeniji, A.O.; Twenter, B.M.; Winkler, J.D.; Christianson, D.W.; Penning, T.M. Bioorg. Med. Chem. Lett., 2012, 22(10), 3492-3497.
[http://dx.doi.org/10.1016/j.bmcl.2012.03.085] [PMID: 22507964]
[51]
Lovering, A.L.; Ride, J.P.; Bunce, C.M.; Desmond, J.C.; Cummings, S.M.; White, S.A. Cancer Res., 2004, 64(5), 1802-1810.
[http://dx.doi.org/10.1158/0008-5472.CAN-03-2847] [PMID: 14996743]
[52]
Marinović, M.A.; Bekić, S.S.; Kugler, M.; Brynda, J.; Škerlová, J.; Škorić, D.Đ.; Řezáčová, P.; Petri, E.T.; Ćelić, A.S. RSC. Med. Chem., 2023, 14(2), 341-355.
[53]
Penning, T.M.; Wangtrakuldee, P.; Auchus, R.J. Endocr. Rev., 2019, 40(2), 447-475.
[http://dx.doi.org/10.1210/er.2018-00089] [PMID: 30137266]
[54]
Byrns, M.C.; Jin, Y.; Penning, T.M. J. Steroid Biochem. Mol. Biol., 2011, 125(1-2), 95-104.
[http://dx.doi.org/10.1016/j.jsbmb.2010.11.004] [PMID: 21087665]
[55]
Davies, N.J.; Hayden, R.E.; Simpson, P.J.; Birtwistle, J.; Mayer, K.; Ride, J.P.; Bunce, C.M. Cancer Res., 2009, 69(11), 4769-4775.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-4533] [PMID: 19487289]
[56]
Savić M.P.; Ajduković J.J.; Plavša, J.J.; Bekić S.S.; Ćelić A.S.; Klisurić O.R.; Jakimov, D.S.; Petri, E.T.; Djurendić E.A. MedChemComm, 2018, 9(6), 969-981.
[http://dx.doi.org/10.1039/C8MD00077H] [PMID: 30108986]
[57]
Li, J.; Tian, Y.; Zhao, L.; Wang, Y.; Zhang, H.; Xu, D.; Zhao, X.; Li, Y. Asian J. Androl., 2016, 18(4), 607-612.
[http://dx.doi.org/10.4103/1008-682X.169997] [PMID: 26698234]
[58]
Hulcová, D.; Breiterová, K.; Zemanová, L.; Siatka, T.; Šafratová, M. Vaněčková, N.; Hošťálková, A.; Wsól, V.; Cahlíková, L. Nat. Prod. Commun., 2017, 12(2), 1934578X1701200.
[http://dx.doi.org/10.1177/1934578X1701200226] [PMID: 30428222]
[59]
Zang, T.; Verma, K.; Chen, M.; Jin, Y.; Trippier, P.C.; Penning, T.M. Chem- Biol. Int., 2015, 234, 339-348.
[60]
Adeniji, A.; Uddin, M.J.; Zang, T.; Tamae, D.; Wangtrakuldee, P.; Marnett, L.J.; Penning, T.M. J. Med. Chem., 2016, 59(16), 7431-7444.
[http://dx.doi.org/10.1021/acs.jmedchem.6b00160] [PMID: 27486833]
[61]
Lolli, M.L.; Carnovale, I.M.; Pippione, A.C.; Wahlgren, W.Y.; Bonanni, D.; Marini, E.; Zonari, D.; Gallicchio, M.; Boscaro, V.; Goyal, P.; Friemann, R.; Rolando, B.; Bagnati, R.; Adinolfi, S.; Oliaro-Bosso, S.; Boschi, D. ACS Med. Chem. Lett., 2019, 10(4), 437-443.
[http://dx.doi.org/10.1021/acsmedchemlett.8b00484] [PMID: 30996776]
[62]
Pippione, A.C.; Carnovale, I.M.; Bonanni, D.; Sini, M.; Goyal, P.; Marini, E.; Pors, K.; Adinolfi, S.; Zonari, D.; Festuccia, C.; Wahlgren, W.Y.; Friemann, R.; Bagnati, R.; Boschi, D.; Oliaro-Bosso, S.; Lolli, M.L. Eur. J. Med. Chem., 2018, 150, 930-945.
[http://dx.doi.org/10.1016/j.ejmech.2018.03.040] [PMID: 29602039]
[63]
Hendriks, C.M.M.; Penning, T.M.; Zang, T.; Wiemuth, D.; Gründer, S.; Sanhueza, I.A.; Schoenebeck, F.; Bolm, C. Bioorg. Med. Chem. Lett., 2015, 25(20), 4437-4440.
[http://dx.doi.org/10.1016/j.bmcl.2015.09.012] [PMID: 26372652]
[64]
Kljun, J.; Anko, M.; Traven, K.; Sinreih, M. Pavlič R.; Peršič Š.; Ude, Ž.; Codina, E.E.; Stojan, J.; Lanišnik Rižner, T.; Turel, I. Dalton Trans., 2016, 45(29), 11791-11800.
[http://dx.doi.org/10.1039/C6DT00668J] [PMID: 27357845]
[65]
Traven, K.; Sinreih, M.; Stojan, J.; Seršen, S.; Kljun, J.; Bezenšek, J.; Stanovnik, B.; Turel, I.; Rižner, T.L. Chem. Biol. Interact., 2015, 234, 349-359.
[http://dx.doi.org/10.1016/j.cbi.2014.11.005]
[66]
Nitta, H.; Takizawa, H.; Mitsumori, T.; Iizuka-Honma, H.; Araki, Y.; Fujishiro, M.; Tomita, S.; Kishikawa, S.; Hashizume, A.; Sawada, T.; Okubo, M.; Sekiguchi, Y.; Ando, M.; Noguchi, M. J. Clin. Med., 2023, 12(19), 6324.
[http://dx.doi.org/10.3390/jcm12196324] [PMID: 37834968]
[67]
He, S.; Liu, Y.; Chu, X.; Li, Q.; Lyu, W.; Liu, Y.; Xing, S.; Feng, F.; Liu, W.; Guo, Q.; Zhao, L.; Sun, H. ACS Med. Chem. Lett., 2022, 13(8), 1286-1294.
[http://dx.doi.org/10.1021/acsmedchemlett.2c00175] [PMID: 35978698]
[68]
Liu, Y.; He, S.; Chen, Y.; Liu, Y.; Feng, F.; Liu, W.; Guo, Q.; Zhao, L.; Sun, H. J. Med. Chem., 2020, 63(20), 11305-11329.
[http://dx.doi.org/10.1021/acs.jmedchem.9b02138] [PMID: 32463235]
[69]
He, S.; Chu, X.; Wu, Y.; Jiang, J.; Fang, P.; Chen, Y.; Liu, Y.; Qiu, Z.; Xiao, Y.; Li, Z.; Pan, D.; Zhang, Q.; Xie, H.; Xing, S.; Feng, F.; Liu, W.; Guo, Q.; Zhao, L.; Yang, P.; Sun, H. J. Med. Chem., 2023, 66(14), 9537-9560.
[http://dx.doi.org/10.1021/acs.jmedchem.3c00213] [PMID: 37409679]
[70]
Ononamadu, C.; Ibrahim, A. BioTechnologia, 2021, 102(1), 85-99.
[http://dx.doi.org/10.5114/bta.2021.103765] [PMID: 36605715]
[71]
Agoni, C.; Olotu, F.A.; Ramharack, P.; Soliman, M.E. J. Mol. Model., 2020, 26(6), 120.
[http://dx.doi.org/10.1007/s00894-020-04385-6]
[72]
Linani, A.; Serseg, T.; Benarous, K.; Bou-Salah, L.; Yousfi, M.; Alama, M.N.; Ashraf, G.M. J. BioStru. Dyn.,; , 2022, pp. 1-14.
[73]
O’Boyle, N.M.; Banck, M.; James, C.A.; Morley, C.; Vandermeersch, T.; Hutchison, G.R. J. Chem., 2011, 3(1), 1-14.
[74]
Jaghoori, M.M.; Bleijlevens, B.; Olabarriaga, S.D. J. Chem. Mol. De., 2016, 30, 237-249.
[75]
Sharma, S.; Kumar, P.; Chandra, R. Lammps; Gromacs, 2019, pp. 329-341.

Rights & Permissions Print Cite
Article Metrics
21
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy